WaveMan
WaveMan · Company
CURI · Curiositystream Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

CURI CuriosityStream (CURI) Insider Trading, Ownership & Congress Trades

Media · Services-motion picture & video tape production · CIK 0001776909
Quote by TradingView
C-suite buying · 1Form 144 · 2
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
51
13F, latest reported quarter
Conversions, 180 days
3
Codes C/M, not in net · no price filed

What the filings say about CURI

Insiders, 180 days
+$375.5K net bought
1 buyer · 2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$309.0K
2 notices

CuriosityStream insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, CuriosityStream Inc. insiders bought a net $375.5K of stock across 135 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Stinchcomb Clinton Larry
President and CEO
BUY
2026-09-01 SECtraded 2026-08-28
20,000
$52.1K
+0.5%
Context
  • 14 earlier Form 4 trades (code P or S) here by this insider (8 buys, 6 sales), the last on Aug 27, 2026.
  • +13.9% median (+19.0% mean) 90-day return after 7 previous buys.
  • The trade is 0.7% of the 3,021,260 shares held after it.
  • No other insider bought within 30 days.
  • 51 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Stinchcomb Clinton Larry bought about $52.1K of CURI on Aug 28, 2026; 51 funds added in the latest 13F quarter.
Stinchcomb Clinton Larry
President and CEO
BUY
2026-08-31 SECtraded 2026-08-27
30,000
$76.6K
+5.2%
Context
  • 13 earlier Form 4 trades (code P or S) here by this insider (7 buys, 6 sales), the last on May 28, 2026.
  • +13.9% median (+19.0% mean) 90-day return after 7 previous buys.
  • The trade is 1.0% of the 3,001,260 shares held after it.
  • No other insider bought within 30 days.
  • 51 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Stinchcomb Clinton Larry bought about $76.6K of CURI on Aug 27, 2026; 51 funds added in the latest 13F quarter.
Hayden Phillip Brady
Chief Financial Officer
SELL
2026-06-16 SECtraded 2026-06-12
30,400
$77.8K
+14.5%
Context
  • 11 earlier Form 4 trades (code P or S) here by this insider (4 buys, 7 sales), the last on Jan 2, 2026.
  • +53.3% median (+55.3% mean) 90-day return after 3 previous buys.
  • The trade is 42.7% of the 71,267 shares held after it.
  • 1 other insider sold within 30 days.
  • 51 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Hayden Phillip Brady sold about $77.8K of CURI on Jun 12, 2026; 1 other insider sold within 30 days and 51 funds added in the latest 13F quarter.
Keeley Patrick J.
Director
SELL
2026-06-16 SECtraded 2026-06-12
31,559
$85.2K
+14.5%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 16.7% of the 188,450 shares held after it.
  • 1 other insider sold within 30 days.
  • 51 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Keeley Patrick J. sold about $85.2K of CURI on Jun 12, 2026; 1 other insider sold within 30 days and 51 funds added in the latest 13F quarter.
Stinchcomb Clinton Larry
President and CEO
BUY
2026-06-01 SECtraded 2026-05-28
25,744
$71.6K
-10.5%
Context
  • 12 earlier Form 4 trades (code P or S) here by this insider (6 buys, 6 sales), the last on May 27, 2026.
  • +16.4% median (+22.2% mean) 90-day return after 6 previous buys.
  • The trade is 0.9% of the 2,971,260 shares held after it.
  • No other insider bought within 30 days.
  • 51 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Stinchcomb Clinton Larry bought about $71.6K of CURI on May 28, 2026; 51 funds added in the latest 13F quarter.
135 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 130 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$375.5K over 180 days
+$128.7K over 90 days
more than 86% of Media
Congress
no House purchase disclosed in the last 12 months
Funds
51 funds bought in last quarter
below 70% of Media
Revenue
+40.1% year over year
more than 88% of Media
Margin
-9.0% net margin
below 60% of Media
Buybacks
$871.0K repurchased, FY to 2026-06-30
below 97% of Media
Short interest
6.7% of the float short (float per yahoo 2026-10-26) · 4.3 days to cover · settled 2026-09-30
more than 68% of Media
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch CURI

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-30.4%12M
-43%-24%-5%+14%2025-102025-122026-022026-042026-062026-082026-10 2025-11-24 · Stinchcomb Clinton Larry sold $656.6K2025-11-25 · Stinchcomb Clinton Larry sold $462.0K2025-11-20 · Stinchcomb Clinton Larry sold $313.3K2026-05-27 · Stinchcomb Clinton Larry bought $258.3K2026-06-12 · Keeley Patrick J. sold $85.2K2026-05-26 · Stinchcomb Clinton Larry bought $80.1K2026-06-12 · Hayden Phillip Brady sold $77.8K2026-08-27 · Stinchcomb Clinton Larry bought $76.6K2026-05-28 · Stinchcomb Clinton Larry bought $71.6K2025-11-20 · HUBERMAN JONATHAN sold $70.6K2025-11-06 · Hayden Phillip Brady sold $67.8K2026-01-02 · Hayden Phillip Brady sold $65.7K2025-11-21 · Stinchcomb Clinton Larry sold $59.2K2026-08-28 · Stinchcomb Clinton Larry bought $52.1K2025-11-20 · Cudahy Theresa Ellen sold $50.8K2025-11-13 · HUBERMAN JONATHAN sold $46.5K2025-12-10 · Cudahy Theresa Ellen sold $28.7K2025-11-13 · Cudahy Theresa Ellen sold $27.7K2025-11-06 · Reed Rebecca R sold $18.5K2025-12-15 · Hayden Phillip Brady sold $9.2K2025-11-17 · Hayden Phillip Brady sold $6.0K2026-09-03 · Hayden Phillip Brady filed to sell $73.0K2026-09-03 · Hayden Phillip Brady filed to sell $236.0K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns CURI: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
2,755,147 sh
$7.3M
VANGUARD CAPITAL MANAGEMENT LLC
1,690,886 sh
$4.5M
RENAISSANCE TECHNOLOGIES LLC
1,528,000 sh
$4.1M
GEODE CAPITAL MANAGEMENT, LLC
1,049,687 sh
$2.8M
LOS ANGELES CAPITAL MANAGEMENT LLC
976,583 sh
$2.6M

Congress trades in CURI

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

CURI planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Hayden Phillip Brady
Filed 2026-09-03
$73.0K
Hayden Phillip Brady
Filed 2026-09-03
$236.0K

CURI mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Ultra-Small Company Fund
$399.0K position · as of 2026-06-30
0.4%
1290 Essex Small Cap Growth Fund
$353.5K position · as of 2026-07-31
0.3%
SIIT SMALL CAP FUND
$352.0K position · as of 2026-05-31
0.2%
SIIT SMALL CAP II FUND
$374.8K position · as of 2026-05-31
0.2%
Small Company Growth Portfolio
$39.1K position · as of 2026-06-30
0.2%
Small Company Value Portfolio
$27.5K position · as of 2026-06-30
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$12.6M
$10.0M
$2.0M
+173%
n/a
2024
$5.6M
$3.2M
$647.5K
+185%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $375.5K bought by insiders over 180 days, 51 funds added last quarter, $309.0K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NFLXROKURDIIBTATZOONXSTADMQCRTOCMPRAMCFLNTTHRY

CURI financials

Revenue growth
+40.1%
XBRL, annual
Net margin
-9.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$76.0M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+0.0%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$5.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
+0.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+0.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-0.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
285.00x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
n/a
no debt line filed
FCF yield
+3.2%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$71.7M$51.1M$56.9M$78.0M
Operating income-$7.3M-$13.3M-$44.5M-$55.3M
Net income-$6.4M-$12.9M-$48.9M-$50.9M
EPS (diluted)-0.11-0.24-0.92-0.96
Operating cash flow$13.1M$8.2M-$16.2M-$39.5M
Cash$18.3M$7.8M$37.7M$40.0M
Buybacks$0$251.0K$0n/a
Dividends paid$22.0M$4.1M$0n/a
SEC XBRL, fiscal years, as known on 2026-10-27

CURI Stock Sonar score 5/7 axes

Find similar shapesCompare

CURI ranks highest on insider conviction (72nd percentile) and growth (69th), and lowest on institutional and government (30th), among Media peers.

ProfitGrowthInsidersInstitutionsRisk
Profitability
53
Inputs
  • Return on equity+0.1% · 53 pct, sector of 61
  • Return on assets+0.0% · 64 pct, sector of 87
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-0.5% · 42 pct, sector of 74
Growth
69
Inputs
  • Revenue growth, YoY+40.1% · 88 pct, sector of 100
  • Backlog growth, YoY+4.4% · 49 pct, universe of 854
Insider conviction
72
Inputs
  • Net Form 4 buying (codes P and S), 180d$376K · 86 pct, sector of 52
  • Insider buyers, 180d1 · 57 pct, sector of 52
Institutional and government
30
Inputs
  • Funds adding, latest quarter51 · 30 pct, sector of 83
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
64
Inputs
  • Short interest, % of float+6.7% · 43 pct, sector of 101
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+6.6% · 85 pct, sector of 73
2 not measured: Financial health, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

CURI filings, in plain words

Are CuriosityStream insiders buying or selling CURI?

In the 180 days to 2026-10-27, CuriosityStream insiders were net buyers, a net $375.5K: $538.6K of purchases and $163.0K of sales reported on Form 4, by 1 buyer and 2 sellers.

Are there planned insider sales of CURI?

Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $309.0K of stock; the latest, by Hayden Phillip Brady, was filed 2026-09-03.

Read the full summary

In the 180 days to 2026-10-27, CuriosityStream insiders were net buyers of CURI, a net $375.5K across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $309.0K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies